Camille Powe, MD, discusses how discontinuing GLP-1 receptor agonists before or during pregnancy may increase gestational weight gain and metabolic risks.
Camille Powe, MD
Advertisement
Camille Powe, MD, is an endocrinologist at Mass General Brigham.
Articles by Camille Powe, MD
Advertisement
Latest Updated Articles
Camille Powe, MD, discusses weight gain from stopping GLP-1RAs in pregnancyPublished: December 3rd 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Review finds no evidence linking prenatal paracetamol use to increased risk of autism, ADHD
2
FDA approves 5-year use for etonogestrel implant 68 mg contraceptive
3
Prenatal factors and offspring risk of adult multiple sclerosis
4
LPCN 1154 for postpartum depression continues clinical process after safety review
5